Circulating insulin-like growth factor-1 and insulin-like growth factor binding protein-3 are associated with early carotid atherosclerosis

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 25, Issue 3, 2005, Pages 617-621

  Kawachi, Shin Ichi ^a   Takeda, Noriyuki ^b   Sasaki, Akihiko ^a   Kokubo, Yoshiaki ^a   Takami, Kazuhisa ^a   Sarui, Hiroshi ^b   Hayashi, Makoto ^c   Yamakita, Noriyoshi ^c   Yasuda, Keigo ^c  

^a GIFU UNIVERSITY   (Japan)

^b ASAHI UNIVERSITY   (Japan)

^c Matsunami General Hospital   (Japan)

Author keywords

Atherosclerosis; Cardiovascular disease; Insulin like growth factor binding protein 3; Insulin like growth factor 1; Metabolic syndrome

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C; TRIACYLGLYCEROL;

ADIPOSE TISSUE; ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; BODY MASS; CARDIOVASCULAR RISK; CELL GROWTH; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; ULTRASOUND;

ADIPOSE TISSUE; ADULT; AGED; BLOOD PRESSURE; BODY MASS INDEX; CAROTID ARTERY DISEASES; EARLY DIAGNOSIS; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; JAPAN; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; RISK FACTORS;

EID: 14644406875     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.0000154486.03017.35     Document Type: Article

References (36)

1. Delafontaine P, Song YH, Li Y. Expression, regulation, and function of IGF-1, IGF-1R, and IGF-1 binding proteins in blood vessels. Arterioscler Thromb Vasc Biol. 2004;24:435-444.
2. Bayes-Genis A, Conover CA, Schwanz RS. The insulin-like growth factor axis: A review of atherosclerosis and restenosis. Circ Res. 2000: 86:125-130.
3. Frystyk J, Ledet T, Møller N, Flyvbjerg A, Ørskov H. Cardiovascular disease and insulin-like growth factor I. Circulation. 2002;106:893-895.
4. Clayton RN. Cardiovascular function in acromegaly. Endocr Rev. 2003; 24:272-277.
5. Rosén T, Bengtsson BÅ. Premature mortality due to cardiovascular disease in hypopituitarism. Lancet. 1990:336:285-288.
6. Carroll PV, Christ ER, Bengtsson BÅ, Carlsson L, Christiansen JS. Clemmons D, Hintz R, Ho K, Laron Z, Sizonenko P, Sönksen PH. Tanaka T, Thorner M. Growth hormone deficiency in adulthood and the effects of growth hormone replacement: a review. Growth Hormone Research Society Scientific Committee. J Clin Endocrinol Metab. 1998;83: 382-395.
7. Pfeifer M, Verhovec R, Žižek B, Preželj J, Poredoš P, Clayton RN. Growth hormone (GH) treatment reverses early atherosclerotic changes in GH-deficient adults. J Clin Endocrinol Metab. 1999:84:453-457.
8. Spallarossa P, Brunelli C, Minuto F, Caruso D, Battistini M. Caponnetto S, Cordera R. Insulin-like growth factor-I and angiographically documented coronary artery disease. Am J Cardiol. 1996;77:200-202.
9. Janssen JAMJL, Stolk RP, Pols HAP, Grobbee DE, Lamberts SWJ. Serum total IGF-I. free IGF-1. and IGFB-1 levels in an elderly population: relation to cardiovascular risk factors and disease. Arterioscler Thromb Vasc Biol. 1998;18:277-282.
10. Conti E, Andreotti F, Sciahbasi A, Riccardi P, Marra G. Menini E, Ghirlanda G. Maseri A. Markedly reduced insulin-like growth factor-1 in the acute phase of myocardial infarction. J Am Coll Cardiol. 2001;38: 26-32.
11. Schuler-Lüttmann S, Mönnig G, Enbergs A, Schulte H, Breithardt G, Assmann G, Kerber S, von Eckardstein A. Insulin-like growth factor-binding protein-3 is associated with the presence and extent of coronary arteriosclerosis. Arterioscler Thromb Vasc Biol. 2000;20:e10-e15.
12. Bøtker HE, Skjærbæk C, Eriksen UH. Schmitz O, Ørskov H. Insulin-like growth factor-1, insulin, and angina pectoris secondary to coronary atherosclerosis, vasospasm, and syndrome X. Am J Cardiol. 1997:79: 961-963.
13. Ruotolo G, Båvenholm P, Brismar K, Eféndic S, Ericsson CG, de Faire U, Nilsson J, Hamsten A. Serum insulin-like growth factor-I level is independently associated with coronary artery disease progression in young male survivors of myocardial infarction: beneficial effects of bezafibrate treatment. J Am Coll Cardiol. 2000;35:647-654.
14. O'Leary DH, Polak JF, Kronmal RA, Manolio TA. Burke GL, Wolfson SK Jr. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group. N Engl J Med. 1999:340:14-22.
15. Rechter MM. Growth inhibition by insulin-like growth factor (IGF) binding protein-3: what's IGF got to do with it? Endocrinology. 1997; 138:2645-2647.
16. Ma J, Pollak MN, Giovannucci E, Chan JM, Tao Y, Hennekens CH, Stampfer MJ. Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-I and IGF-binding protein-3. J Natl Cancer Inst. 1999:91:620-625.
17. Takami R, Takeda N, Hayashi M, Sasaki A, Kawachi S, Yoshino K, Takami K. Nakashima K, Akai A, Yamakita N, Yasuda K. Body fatness and fat distribution as predictors of metabolic abnormalities and early carotid atherosclerosis. Diabetes Care. 2001:24:1248-1252.
18. Sato M, Takeda N, Sarui H, Takami R, Takami K, Hayashi M, Sasaki A, Kawachi S, Yoshino K, Yasuda K. Association between serum leptin concentrations and bone mineral density, and biochemical markers of bone turnover in adult men. J Clin Endocrinol Metab. 2001;86: 5273-5276.
19. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985:28:412-419.
20. Pignoli P, Tremoli E. Poli A, Oreste P, Paoletti R. Intimal plus medial thickness of the arterial wall: a direct measurement with ultrasound imaging. Circulation. 1986;74:1399-1406.
21. Yoshiike N, Matsumura Y, Zaman MM, Yamaguchi M. Descriptive epidemiology of body mass index in Japanese adults in a representative sample from the National Nutrition Survey 1990-1994. Int J Obes Relat Metab Disord. 1998;22:684-687.
22. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care. I997;20:1183-1197.
23. Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure. The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Arch Intern Med. 1997:157:2413-2446.
24. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol In Adults. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA. 2001;285:2486-2497.
25. Thissen JP, Ketelslegers JM, Underwood LE. Nutritional regulation of the insulin-like growth factors. Endocr Rev. 1994:15:80-101.
26. Thissen JP. Verniers J. Inhibition by interleukin (IL)-Iβ and tumor necrosis factor-α of the insulin-like growth factor I messenger ribonucleic acid response to growth hormone in rat hepatocyte primary culture. Endocrinology. 1997;138:1078-1084.
27. Marx N. Neumann FJ, Ott I, Gawaz M, Koch W, Pinkau T, Schomig A. Induction of cytokine expression in leukocytes in acute myocardial infarction. J Am Coll Cardiol. 1997;30:165-170.
28. Lee W-L, Chen J-W, Ting C-T, Lin S-J, Wang PH. Changes of the insulin-like growth factor I system during acute myocardial infarction: implications on left ventricular remodeling. J Clin Endocrinol Metab. 1999;84:1575-1581.
29. Capaldo B, Patti L, Oliviero U. Longobardi S, Pardo F, Vitale F, Fazio S, Di Rella F, Biondi B, Lombardi G, Sacca L. Increased arterial intima-media thickness in childhood-onset growth hormone deficiency. J Clin Endocrinol Metab. 1997:82:1378-1381.
30. Colao A, Spiezia S, Cerbone G, Pivonello R, Marzullo P, Ferone D, Di Somma C, Assanti AP, Lombardi G. Increased arterial intima-media thickness by B-M mode echodoppler ultrasonography in acromegaly. Clin Endocrinol (Oxf). 2001 ;54:515-524.
31. Jones JI, Clemmons DR. Insulin-like growth factors and their binding proteins: biological actions. Endocr Rev. 1995:16:3-34.
32. Baxter RC. Insulin-like growth factor (IGF)-binding proteins: interactions with IGFs and intrinsic bioactivities. Am J Physiol Endocrinol Metab. 2000;278:E967-E976.
33. Juul A, Scheike T. Davidsen M, Gyllenborg J, Jørgensen T. Low serum insulin-like growth factor I is associated with increased risk of ischemic heart disease: a population-based case-control study. Circulation. 2002; 106:939-944.
34. Denarié N, Gariepy J, Chironi G, Massonneau M, Laskri F, Salomon J, Levenson J, Simon A. Distribution of ultrasonographically-assessed dimensions of common carotid arteries in healthy adults of both sexes. Atherosclerosis. 2000; 148:297-302.
35. Scott CD, Baxter RC. Production of insulin-like growth factor I and its binding protein in rat hepatocytes cultured from diabetic and insulin-treated diabetic rats. Endocrinology. 1986:119:2346-2352.
36. Després JP. Lamarche B. Mauriége P, Cantin B. Dagenais GR, Moorjani S, Lupien PJ. Hyperinsulinemia as an independent risk factor for ischemic heart disease. N Engl J Med. 1996:334:952-957.